Orleans Parish woman sues manufacturer of NuvaRing after developing blood clot
NEW ORLEANS-Jenny Lorusso has filed suit against the manufacturers of the birth control product NuvaRing, alleging the product caused her to suffer a blood clot within a vein.
Lorusso filed suit against Organon Pharmaceuticals USA, Organon International and Schering-Plough Corp. on July 16 in federal court in New Orleans.
She claims she was prescribed NuvaRing in January 2005 and suffered a venous thromboembolism after she began using the drug. Lorusso says it was not until August 2009 that she became aware of the risks associated with NuvaRing through an advertisement.
Lorusso says the drug has a higher risk of thrombotic events as compared to the birth control pill.
The defendants are accused of wrongful conduct including the design, manufacture, distribution, testing, labeling, and failure to warn; failure to warn properly of harmful side effects; warranting and sale of the contraceptive, NuvaRing.
Lorusso is seeking damages for physical pain and suffering, mental and emotional pain, permanent disability, suffering, fear, anguish, all expenses and all losses, compensatory damages for medical expenses, lost wages and loss of earning capacity, medical monitoring expenses, refund of the cost of NuvaRing prescription, interest and court costs.
Lorusso is represented by Allan Berger and Andrew Geiger of Allan Berger & Associates in New Orleans. A jury trial is requested.
U.S. District Judge Ivan L.R. Lemelle is assigned to the case.
Case No. 2:10cv02000